Bausch Health Companies Stock Performance
| BHC Stock | USD 8.37 0.25 3.08% |
On a scale of 0 to 100, Bausch Health holds a performance score of 13. The firm shows a Beta (market volatility) of -0.17, which signifies not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Bausch Health are expected to decrease at a much lower rate. During the bear market, Bausch Health is likely to outperform the market. Please check Bausch Health's potential upside, skewness, and the relationship between the maximum drawdown and semi variance , to make a quick decision on whether Bausch Health's price patterns will revert.
Risk-Adjusted Performance
13 of 100
Weak | Strong |
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Bausch Health Companies are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak technical indicators, Bausch Health exhibited solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 3.08 | Five Day Return 4.23 | Year To Date Return 7.58 | Ten Year Return (94.26) | All Time Return 1.6 K |
Last Split Factor 2:1 | Ex Dividend Date 2010-11-10 | Last Split Date 2000-10-16 |
1 | Disposition of 13370 shares by Seana Carson of Bausch Health at 6.21 subject to Rule 16b-3 | 09/06/2024 |
2 | Acquisition by John Paulson of 7659 shares of Bausch Health at 8.16 subject to Rule 16b-3 | 09/30/2024 |
3 | Shareholders in Bausch Health Companies are in the red if they invested three years ago | 10/02/2024 |
4 | Provident Healthcare Partners Advises Birmingham Heart Clinic in its Partnership with U.S. Heart Vascular | 10/21/2024 |
5 | Bausch Health Companies Q3 2024 Earnings Preview | 10/29/2024 |
6 | Q3 2024 Bausch Health Companies Inc Earnings Call Transcript | 10/31/2024 |
7 | Bausch Health Companies Announces Quarterly Earnings Results | 11/01/2024 |
8 | Why Bausch Health is a Top Momentum Stock for the Long-Term | 11/04/2024 |
9 | Are Medical Stocks Lagging Bausch Health This Year | 11/06/2024 |
10 | John Paulsons Strategic Moves in Q3 2024 A Focus on Anglogold Ashanti PLC | 11/15/2024 |
| Begin Period Cash Flow | 591 M |
Bausch |
Bausch Health Relative Risk vs. Return Landscape
If you would invest 607.00 in Bausch Health Companies on September 2, 2024 and sell it today you would earn a total of 230.00 from holding Bausch Health Companies or generate 37.89% return on investment over 90 days. Bausch Health Companies is generating 0.5508% of daily returns assuming volatility of 3.178% on return distribution over 90 days investment horizon. In other words, 28% of stocks are less volatile than Bausch, and above 90% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Bausch Health Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Bausch Health's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Bausch Health Companies, and traders can use it to determine the average amount a Bausch Health's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1733
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | BHC | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.18 actual daily | 28 72% of assets are more volatile |
Expected Return
| 0.55 actual daily | 10 90% of assets have higher returns |
Risk-Adjusted Return
| 0.17 actual daily | 13 87% of assets perform better |
Based on monthly moving average Bausch Health is performing at about 13% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bausch Health by adding it to a well-diversified portfolio.
Bausch Health Fundamentals Growth
Bausch Stock prices reflect investors' perceptions of the future prospects and financial health of Bausch Health, and Bausch Health fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Bausch Stock performance.
| Return On Equity | -23.05 | ||||
| Return On Asset | 0.0415 | ||||
| Profit Margin | (0.02) % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 23.93 B | ||||
| Shares Outstanding | 367.8 M | ||||
| Price To Earning | 9.26 X | ||||
| Price To Book | 18.78 X | ||||
| Price To Sales | 0.32 X | ||||
| Revenue | 8.76 B | ||||
| Gross Profit | 5.76 B | ||||
| EBITDA | 2.24 B | ||||
| Net Income | (611 M) | ||||
| Cash And Equivalents | 564 M | ||||
| Cash Per Share | 1.34 X | ||||
| Total Debt | 22.39 B | ||||
| Current Ratio | 1.05 X | ||||
| Book Value Per Share | (3.19) X | ||||
| Cash Flow From Operations | 1.03 B | ||||
| Earnings Per Share | (0.48) X | ||||
| Market Capitalization | 3.08 B | ||||
| Total Asset | 27.35 B | ||||
| Retained Earnings | (9.78 B) | ||||
| Working Capital | 1.29 B | ||||
| Current Asset | 984.02 M | ||||
| Current Liabilities | 730.59 M | ||||
About Bausch Health Performance
By analyzing Bausch Health's fundamental ratios, stakeholders can gain valuable insights into Bausch Health's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Bausch Health has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Bausch Health has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 220.23 | 128.82 | |
| Return On Tangible Assets | (0.06) | (0.06) | |
| Return On Capital Employed | 0.04 | 0.04 | |
| Return On Assets | (0.02) | (0.02) | |
| Return On Equity | 0.58 | 0.61 |
Things to note about Bausch Health Companies performance evaluation
Checking the ongoing alerts about Bausch Health for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Bausch Health Companies help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Bausch Health appears to be risky and price may revert if volatility continues | |
| The company reported the last year's revenue of 8.76 B. Reported Net Loss for the year was (611 M) with profit before taxes, overhead, and interest of 5.76 B. | |
| Bausch Health has a strong financial position based on the latest SEC filings | |
| About 71.0% of the company shares are held by institutions such as insurance companies | |
| Latest headline from gurufocus.com: John Paulsons Strategic Moves in Q3 2024 A Focus on Anglogold Ashanti PLC |
- Analyzing Bausch Health's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Bausch Health's stock is overvalued or undervalued compared to its peers.
- Examining Bausch Health's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Bausch Health's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Bausch Health's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Bausch Health's stock. These opinions can provide insight into Bausch Health's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Bausch Stock analysis
When running Bausch Health's price analysis, check to measure Bausch Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bausch Health is operating at the current time. Most of Bausch Health's value examination focuses on studying past and present price action to predict the probability of Bausch Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bausch Health's price. Additionally, you may evaluate how the addition of Bausch Health to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios |